Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

FDA issues complete response letter for Ryanodex

July 27, 2017

Unity Biotechnology patents Bcl-W, Bcl-XL and Bcl-2 inhibitors

July 12, 2017

GlaxoSmithKline describes novel CPHPC prodrugs

May 24, 2017

FDA grants priority review to Ryanodex NDA to treat exertional heat stroke

March 28, 2017

Santen Pharmaceutical patents glucocorticoid receptor agonists

March 24, 2017

Mouse model developed for the study of alpha-gal meat allergy

March 14, 2017

TiGenix initiates phase Ib/IIa trial of Cx-611 to treat sepsis in community-acquired pneumonia

Jan. 31, 2017

Eagle Pharmaceuticals completes NDA submission for Ryanodex

Jan. 24, 2017

AnaMar reports 5-HT2B receptor antagonists

Jan. 17, 2017

AdAlta reports additional preclinical data for AD-114 in lung and liver fibrosis

Jan. 11, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 2, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 2, 2025.
CMS vows to put more emphasis on MA plans’ prior authorization
BioWorld MedTech
Physicians aren’t the only ones who see prior authorization (PA) practices as a significant problem, but John Brooks, deputy administrator at CMS, told a med tech...
Filling the NIH funding gap to protect biopharma research
BioWorld
The Trump administration’s broad slash to university research budgets raises pertinent questions over impacts to the biopharma ecosystem, specifically how a...
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...